SCHEMBL8105141

SCHEMBL8105141

O=S(O)c1ccc(F)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
HTT P42858 3/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 2/20 0.39
PIK3CA P42336 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
IDO1 P14902 1/20 0.37
ERCC1 P07992 1/20 0.37
ERCC4 Q92889 1/20 0.37
RPA1 P27694 1/20 0.37
ITGB3 P05106 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3928731 0.98 SLC2A1 (0.40) SLC2A1MEN1KMT2AHTTMAPT
SCHEMBL4425404 0.80 CES2 (0.43) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL11228437 0.80 HSD17B10 (0.42) KMT2AALDH1A1TSHRIDO1
SCHEMBL3926817 0.78 CES2 (0.41) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL3928729 0.78 SOS1 (0.37) SLC2A1MEN1KMT2AHTTMAPT
SCHEMBL26204831 0.77 TSHR (0.48) ALDH1A1TSHRLMNASMN1; SMN2
SCHEMBL7937183 0.75 CYP3A4 (0.43) HTTMAPTALDH1A1NPC1RAB9A
SCHEMBL10078846 0.75 TSHR (0.47) ALDH1A1TSHRSMN1; SMN2
SCHEMBL25612801 0.75 MAPT (0.41) MEN1KMT2AHTTMAPTALDH1A1
SCHEMBL20048736 0.75 HTT (0.39) SLC2A1MEN1KMT2AHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase Oxford Drug Design Limited (GB) 2023-10-31 US disclosed
US-20200039929-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE INHIBOX LIMITED (GB) 2020-02-06 US disclosed
US-20090018134-A1 Compounds - 945 ASTRAZENECA AB (SE) 2009-01-15 US disclosed
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed
EP-0107622-B1 BENZODIOXOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM CIBA-GEIGY AG (CH) 1987-11-11 EP disclosed
US-4600709-A ANTIEDEMIC, HYPOTENSIVE, DIURETIC CIBA-GEIGY AG (CH) 1986-07-15 US disclosed
EP-0107622-A1 Benzodioxole derivatives, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1984-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018134-A1 Compounds - 945 MTOR, PIK3CA, PIK3R5 SLC2A1 1646/4885MEN1 1362/4885KMT2A 2445/4885
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase AARS1, NSUN3, GARS1 SLC2A1 2575/4885MEN1 4816/4885KMT2A 483/4885
US-20200039929-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE AARS1, NSUN3, GARS1 SLC2A1 2575/4885MEN1 4816/4885KMT2A 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.